Literature DB >> 33761955

Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.

Shingo Ota1, Makoto Orii2, Tsuyoshi Nishiguchi1, Mao Yokoyama1, Ryoko Matsushita3, Kazushi Takemoto1, Takashi Tanimoto1, Kumiko Hirata4, Takeshi Hozumi1, Takashi Akasaka1.   

Abstract

BACKGROUND: Non-ischemic cardiomyopathy (NICM) is a heterogeneous disease, and its prognosis varies. Although late gadolinium enhancement (LGE)-cardiovascular magnetic resonance (CMR) demonstrates a linear pattern in the mid-wall of the septum or multiple LGE lesions in patients with NICM, the therapeutic response and prognosis of multiple LGE lesions have not been elucidated. This study aimed to investigate the frequency of left ventricular (LV) reverse remodeling (LVRR) and prognosis in patients with NICM who have multiple LGE lesions.
METHODS: This single-center retrospective study included 101 consecutive patients with NICM who were divided into 3 groups according to LGE-CMR results: patients without LGE (no LGE group = 48 patients), patients with a typical mid-wall LGE pattern (n = 29 patients), and patients with multiple LGE lesions (n = 24 patients). LVRR was defined as an increase in LV ejection fraction (LVEF) ≥ 10 % and a final value of LVEF > 35 %, which was accompanied by a decrease in LV end-systolic volume ≥ 15 % at 12-month follow-up using echocardiography. The frequency of composite cardiac events, defined as sudden cardiac death (SCD), aborted SCD (non-fatal ventricular fibrillation, sustained ventricular tachycardia, or adequate implantable cardioverter-defibrillator therapies), and heart failure death or hospitalization for worsening heart failure, were summarized and compared between the groups.
RESULTS: Among the 3 groups, the frequency of LVRR was significantly lower in the multiple lesions group than in the no LGE and mid-wall groups (no LGE vs. mid-wall vs. multiple lesions: 49 % vs. 52 % vs. 19 %, p = 0.03). There were 24 composite cardiac events among the patients: 2 in patients without LGE (hospitalization for worsening heart failure; 2), 7 in patients of the mid-wall group (SCD; 1, aborted SCD; 1 and hospitalization for worsening heart failure; 5), and 15 in patients of the multiple lesions group (SCD; 1, aborted SCD; 8 and hospitalization for worsening heart failure; 6). The multiple LGE lesions was an independent predictor of composite cardiac events (hazard ratio: 11.40 [95 % confidence intervals: 1.49-92.01], p = 0.020).
CONCLUSIONS: Patients with multiple LGE lesions have a higher risk of cardiac events and poorer LVRR. The LGE pattern may be useful for an improved risk stratification in patients with NICM.

Entities:  

Keywords:  Cardiovascular magnetic resonance; Multiple late gadolinium enhancement lesions; Non‐ischemic cardiomyopathy; Reverse remodeling

Year:  2021        PMID: 33761955      PMCID: PMC7992777          DOI: 10.1186/s12968-021-00734-3

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  27 in total

1.  Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography.

Authors:  Rainer Hoffmann; Stephan von Bardeleben; Folkert ten Cate; Adrian C Borges; Jaroslaw Kasprzak; Christian Firschke; Stephane Lafitte; Nidal Al-Saadi; Stefanie Kuntz-Hehner; Marc Engelhardt; Harald Becher; Jean Louis Vanoverschelde
Journal:  Eur Heart J       Date:  2004-12-17       Impact factor: 29.983

2.  Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study.

Authors:  Dennis M McNamara; Randall C Starling; Leslie T Cooper; John P Boehmer; Paul J Mather; Karen M Janosko; John Gorcsan; Kevin E Kip; G William Dec
Journal:  J Am Coll Cardiol       Date:  2011-09-06       Impact factor: 24.094

Review 3.  Differentiation of myocardial scar from potential pitfalls and artefacts in delayed enhancement MRI.

Authors:  E B Turkbey; M S Nacif; R A Noureldin; C T Sibley; S Liu; J A C Lima; D A Bluemke
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

4.  Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy.

Authors:  Jin-Oh Choi; Eun Young Kim; Ga Yeon Lee; Sang-Chol Lee; Seung Woo Park; Duk-Kyung Kim; Jae K Oh; Eun-Seok Jeon
Journal:  Circ J       Date:  2012-10-24       Impact factor: 2.993

5.  Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.

Authors:  Francisco Leyva; Robin J Taylor; Paul W X Foley; Fraz Umar; Lawrence J Mulligan; Kiran Patel; Berthold Stegemann; Tarek Haddad; Russell E A Smith; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2012-09-26       Impact factor: 24.094

6.  Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR.

Authors:  Olga Bondarenko; Aernout M Beek; Mark B M Hofman; Harald P Kühl; Jos W R Twisk; Willem G van Dockum; Cees A Visser; Albert C van Rossum
Journal:  J Cardiovasc Magn Reson       Date:  2005       Impact factor: 5.364

7.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

Authors:  Leah Iles; Heinz Pfluger; Lisa Lefkovits; Michelle J Butler; Peter M Kistler; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

8.  Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy.

Authors:  Milos Kubanek; Marek Sramko; Jana Maluskova; Dana Kautznerova; Jiri Weichet; Petr Lupinek; Jana Vrbska; Ivan Malek; Josef Kautzner
Journal:  J Am Coll Cardiol       Date:  2013-01-08       Impact factor: 24.094

9.  Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.

Authors:  Hiroto Tsujioka; Toshio Imanishi; Hideyuki Ikejima; Akio Kuroi; Shigeho Takarada; Takashi Tanimoto; Hironori Kitabata; Keishi Okochi; Yu Arita; Kohei Ishibashi; Kenichi Komukai; Hideaki Kataiwa; Nobuo Nakamura; Kumiko Hirata; Atsuhsi Tanaka; Takashi Akasaka
Journal:  J Am Coll Cardiol       Date:  2009-07-07       Impact factor: 24.094

Review 10.  Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.

Authors:  Brian P Halliday; John G F Cleland; Jeffrey J Goldberger; Sanjay K Prasad
Journal:  Circulation       Date:  2017-07-11       Impact factor: 29.690

View more
  3 in total

Review 1.  Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction.

Authors:  Michele Correale; Pietro Mazzeo; Lucia Tricarico; Francesca Croella; Martino Fortunato; Michele Magnesa; Marco Amatruda; Simona Alfieri; Salvatore Ferrara; Vincenzo Ceci; Giuseppe Dattilo; Marco Mele; Massimo Iacoviello; Natale Daniele Brunetti
Journal:  Clin Drug Investig       Date:  2022-06-20       Impact factor: 2.859

2.  Reducing CIED-Related Morbidity: "LESS Is More".

Authors:  François D Regoli
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

3.  Usefulness of Cardiovascular Magnetic Resonance Imaging in a Patient with Cardiac Involvement of Systemic Sclerosis.

Authors:  Shingo Ota; Motoki Taniguchi; Yosuke Katayama; Yuichi Ozaki; Keisuke Satogami; Yasushi Ino; Naoki Yamamoto; Koji Onoda; Atsushi Tanaka
Journal:  Intern Med       Date:  2021-11-27       Impact factor: 1.282

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.